Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
February 18, 2014
Patent Application Number
10550152
Date Filed
March 22, 2004
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is directed to novel double-stranded short interfering (siRNA) analogues comprising locked nucleic acid (LNA) monomers. Such compounds induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). The compounds disclosed herein has improved properties compared to non-modified siRNAs and may, accordingly, be useful as therapeutic agents, e.g., in the treatment of various cancer forms. More particularly, the present invention is directed to siRNA analogues comprising a sense strand and an antisense strand, wherein each strand comprises 12-35 nucleotides and wherein the siRNA analogues comprise at least one locked nucleic acid (LNA) monomer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
